The BinaxNOW™ G6PD Test is a rapid test for the qualitative detection of G6PD enzyme activity in human venous whole blood. The simple, three step test provides results in less than 10 minutes, allowing for prompt treatment decisions.

STANDARD G6PD is a quantitative glucose-6-phosphate dehydrogenase (G6PD) enzyme activity analyzer. Due to its portable size, it can be more easily stored and moved; the convenience of the test strips has been maximized by enabling storage at room temperature.

World’s first G6PD quantitative test in 4 minutes. Awareness of G6PD deficiency has grown significantly in the healthcare community. Along with the use of the antimalarial drug primaquine and every-day life, health care individuals are looking to educate more about the health conditions of G6PD deficiency.

The STANDARD G6PD Test System is indicated for differentiating normal, intermediate, and deficient G6PD activity levels to aid in the detection of G6PD deficiency in individuals and in the determination of hemoglobin levels.

Results are provided within two minutes on a portable, handheld analyzer and used to classify individuals as G6PD normal, intermediate, or deficient according to the manufacturer’s recommended thresholds.

This article describes three studies designed to evaluate the (i) performance of a point-of-care test against blood specimens with multiple blood disorders; (ii) precision of the test on multiple G6PD finger replicates; and (iii) diagnostic performance of the test on both fingerstick and venous specimens across three point-of-care settings ...

Quantitative G6PD point-of-care (POC) tests are an important tool for wider and safer use of 8-aminoquinolines which are needed for malaria elimination, for safe prescription of oxidative drugs in common clinical conditions, and for a more accurate diagnosis of G6PD deficiency at birth to improve the diagnosis and management of neonatal ...

Demonstrating usability of new quantitative point-of-care (POC) G6PD diagnostic tests by locally trained clinical staff can inform clinical deployment in this setting and in other rural settings. This study assessed the technical performance and usability of the ‘STANDARD G6PD’ (SD Biosensor, Korea) test when used by trained midwives in two ...

The G6PD point-of-care test allows doctors to test patients for G6PD deficiency and receive results within two minutes. The device requires taking a pin prick of blood, which is tested in the analyzer.

More affordable, accurate, point-of-care (POC) tests for G6PD deficiency are emerging that create an opportunity to extend testing to populations that do not have access to high throughput screening services.